HR 4393 116th Congress House Health Birth defects Cancer Cardiovascular and respiratory health Congressional oversight Digestive and metabolic diseases Genetics Government studies and investigations Health care coverage and access Health care quality Health personnel Health programs administration and funding Health promotion and preventive care Hospital care Medicaid Medical research Medical tests and diagnostic methods Neurological disorders State and local finance State and local government operations

Advancing Access to Precision Medicine Act

Introduced: September 18, 2019 See on congress.gov

Everywhere this bill has been 3 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Sep 19, 2019

Referred to the Subcommittee on Health.

Sep 18, 2019

Referred to the House Committee on Energy and Commerce.

Sep 18, 2019

Introduced in House

Plain-English summary Congressional Research Service

Advancing Access to Precision Medicine Act

This bill allows state Medicaid programs to cover DNA sequencing clinical services for certain individuals.

Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to a pediatric intensive care unit and seen by a medical specialist for a chronic or undiagnosed disease, and (2) are suspected by a medical specialist to have a pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.

Additionally, the National Academy of Medicine must study the effects of genetic and genomic testing and ways to expand health insurance coverage of such services, including under Medicare and Medicaid.

What's happening now September 19, 2019

Referred to the Subcommittee on Health.

Committees of jurisdiction 2